2022
DOI: 10.1007/s00415-022-11268-8
|View full text |Cite
|
Sign up to set email alerts
|

Sarcopenia and nervous system disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(25 citation statements)
references
References 120 publications
0
14
0
Order By: Relevance
“…A low BMI was an independent risk factor for seizures after LT. Low BMI was considered an indicator of sarcopenia in our LT population, which has been shown to be related to neurological disorders such as dementia, ischemic stroke, depression, and cognitive impairment in recent studies [ 28 ]. Dopaminergic dysfunction, neuronal hypoexcitability, brain atrophy, and neuromuscular junction dysfunction are the regulatory processes associated with the pathophysiology of sarcopenia.…”
Section: Discussionmentioning
confidence: 99%
“…A low BMI was an independent risk factor for seizures after LT. Low BMI was considered an indicator of sarcopenia in our LT population, which has been shown to be related to neurological disorders such as dementia, ischemic stroke, depression, and cognitive impairment in recent studies [ 28 ]. Dopaminergic dysfunction, neuronal hypoexcitability, brain atrophy, and neuromuscular junction dysfunction are the regulatory processes associated with the pathophysiology of sarcopenia.…”
Section: Discussionmentioning
confidence: 99%
“…In a meta-analysis of studies published in 2022, the occurrence of sarcopenia ranged from 10% to 27%, with the occurrence of severe sarcopenia falling within a range of 2%-9% (Petermann-Rocha et al, 2022). Both primary sarcopenia associated with aging as well as secondary sarcopenia resulting from other medical conditions, including neurological disorders, typically begin to occur in middle age and progress thereafter Yang et al, 2022). Evidence suggests that sarcopenia can co-occur in various neurological diseases, such as Parkinson's disease, multiple sclerosis, stroke, dementia, and myasthenia gravis (Cai et al, 2021;Cho et al, 2022;Ryan et al, 2017;Yang et al, 2022).…”
Section: Introductionmentioning
confidence: 99%
“…However, research regarding the relationship between sarcopenia and epilepsy is lacking. Dysfunction in mitochondria, neuromuscular signaling, endocrine factors, and inflammation play a significant role in the development of sarcopenia, which is more common in patients with epilepsy than in healthy individuals (Bakhtadze et al., 2021; Cruz‐Jentoft & Sayer, 2019; McNamara et al., 2017; Waldbaum & Patel, 2010; Yang et al., 2022). In addition, sleep disturbance is prevalent among patients with epilepsy, which is also considered one of the contributing factors to sarcopenia (Koike et al., 2023; Smith et al., 2022).…”
Section: Introductionmentioning
confidence: 99%
“…Sarcopenia is also associated with many diseases other than the musculoskeletal system. These can be either acute or chronic, and affect millions of people all over the world [5][6][7]. Overall, it results in an inability to perform daily tasks, dependence on the care of others, and an increased morbidity and mortality rate [8][9][10].…”
Section: Introductionmentioning
confidence: 99%